Broad Genomic Testing Linked to Longer Survival in Advanced Lung Cancer According to New Study in JNCCN
Researchers found comprehensive biomarker testing before starting treatment for advanced lung cancer, as recommended in the NCCN Guidelines, was associated with patients living longer. PLYMOUTH MEETING, Pa., Nov. 12, 2026 /PRNewswire/ -- New research in the November 2026 issue of...
Covered in this story
Call it yourself
No calls on $ASB yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Associated Bancorp →Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.